CanSinoBIO's COVID-19 vaccine received the authorization of WHO (World Health Organization).
The international health agency decided to say yes to China's new one-shot coronavirus vaccine after the medicine met its health standards.
"Today, the World Health Organization (WHO) issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino Biologics," said WHO via its official news release.
The World Health Organization that Convidecia has been added to the growing COVID-19 vaccine portfolio.
CanSinoBIO COVID-19 Vaccine
According to The StraitTimes' latest report, the COVID-19 vaccine of CanSinoBIO, a Chinese vaccine manufacturer, is a single-shot coronavirus medicine.
This means that patients only need to have one vaccine jab. It is also the third Chinese-made COVID-19 vaccine that received WHO's authorization.
When it comes to efficiency, it is 92% effective against severe COVID-19 symptoms. Meanwhile, Convidecia has a 64% efficacy against symptomatic disease.
The World Health Organization explained that Convidecia was approved since it meets the vaccine standards it implements. This means that CanSinoBIO-manufactured medicine's benefits outweigh the risks.
As of writing, WHO said that patients aged 18 and above could already take the new COVID-19 vaccine. CanSinoBIO is already rolling out its new product in Argentina, Malaysia, Mexico, Pakistan, Chile, and China.
Convidecia as a New Vaccine Under WHO's EUL
Before WHO approved the new Convidecia vaccine, there were only eight vaccines under its EUL (Emergency Use Listing).
These include Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, and Novavax. But, thanks to the performance of Convidecia, it is now among the vaccines under WHO's EUL.
If you want to see further details about the new Chinese COVID-19 vaccine, you can visit this link.
Previously, the new COVID-19 breath test tech was approved by FDA.
On the other hand, the first North Korea COVID-19 lockdown was confirmed after cases were identified in the Asian country.
For more news updates about the COVID-19 vaccine and other related health topics, always keep your tabs open here at TechTimes.
Related Article : Moderna COVID-19 Vaccine for 6-Month-Old Babies? FDA Authorization Achieved After Successful Trials
This article is owned by TechTimes
Written by: Griffin Davis
